Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

TransTech, Novo Nordisk deal

September 26, 2005 7:00 AM UTC

TransTech received an undisclosed milestone payment from NVO under a 2001 deal. Under the deal, TransTech is using its Translational Technology on NVO targets to identify and validate small molecule t...